Lily Du Yan1, Kristin Dean2, Daniel Park3, James Thompson2, Ian Tong2,4, Cindy Liu3, Rana F Hamdy5,6,7. 1. Boston Medical Center, , Boston, MA, USA. 2. Doctor On Demand, Professional Corporation, , San Francisco, CA, USA. 3. Antibiotic Resistance Action Center, Department of Environmental and Occupational Health, George Washington Milken Institute of Public Health, , Washington, DC, USA. 4. Stanford University School of Medicine, , Stanford, CA, USA. 5. Antibiotic Resistance Action Center, Department of Environmental and Occupational Health, George Washington Milken Institute of Public Health, , Washington, DC, USA. rhamdy@childrensnational.org. 6. Division of Infectious Diseases, Children's National Hospital, , Washington, DC, USA. rhamdy@childrensnational.org. 7. George Washington University School of Medicine and Health Sciences, , Washington, DC, USA. rhamdy@childrensnational.org.
Abstract
BACKGROUND: Antibiotics prescribed for acute respiratory tract infections in the telemedicine setting are often unwarranted. OBJECTIVE: We hypothesized that education plus individualized feedback, compared with education alone, would significantly reduce antibiotic prescription rates for upper respiratory infections, bronchitis, sinusitis, and pharyngitis in a telemedicine setting. DESIGN: Two-arm, parallel-group randomized controlled trial conducted at a telemedicine practice from January 1, 2018, to November 30, 2018. PARTICIPANTS: Clinicians employed at the practice on or after January 1, 2017 (n = 45). INTERVENTIONS: The control group received education (treatment guideline presentation and online course) in April 2018. The intervention group received education plus individualized feedback via an online dashboard with monthly rates of personal and practice-wide antibiotic prescription rates starting May 2018. MAIN MEASURES: Antibiotic prescription for any visit with at least one target condition: upper respiratory tract infection, bronchitis, sinusitis, and pharyngitis. KEY RESULTS: Baseline antibiotic prescription rates in control and intervention groups across conditions were as follows: upper respiratory infection (URI): 626/3410 (18.4%), 413/2752 (15.0%), bronchitis: 689/1471 (46.8%), 742/1162 (64.0%), sinusitis: 5154/6131 (84.1%), 4250/4876 (87.2%), pharyngitis: 2308/2838 (81.3%), 1593/2126 (74.9%). Antibiotic prescriptions for all conditions decreased in the post-intervention period compared with those in the pre-intervention period, for both control and intervention groups. Reduction of antibiotic prescriptions for URI and bronchitis was greater for the group receiving education plus individualized feedback compared with that for the group receiving education alone (interaction term ratio 0.60, 95% CI 0.47 to 0.77 for URI; and interaction term ratio 0.42, 95% CI 0.32 to 0.55 for bronchitis), but not sinusitis and pharyngitis. CONCLUSION: Education plus individualized feedback in a telemedicine practice significantly decreased antibiotic prescription rates for upper respiratory tract infections and bronchitis, compared with education alone. Future studies should focus on tailoring antibiotic stewardship programs based on underlying conditions, and the maintenance of early reductions in antibiotic prescription.
BACKGROUND: Antibiotics prescribed for acute respiratory tract infections in the telemedicine setting are often unwarranted. OBJECTIVE: We hypothesized that education plus individualized feedback, compared with education alone, would significantly reduce antibiotic prescription rates for upper respiratory infections, bronchitis, sinusitis, and pharyngitis in a telemedicine setting. DESIGN: Two-arm, parallel-group randomized controlled trial conducted at a telemedicine practice from January 1, 2018, to November 30, 2018. PARTICIPANTS: Clinicians employed at the practice on or after January 1, 2017 (n = 45). INTERVENTIONS: The control group received education (treatment guideline presentation and online course) in April 2018. The intervention group received education plus individualized feedback via an online dashboard with monthly rates of personal and practice-wide antibiotic prescription rates starting May 2018. MAIN MEASURES: Antibiotic prescription for any visit with at least one target condition: upper respiratory tract infection, bronchitis, sinusitis, and pharyngitis. KEY RESULTS: Baseline antibiotic prescription rates in control and intervention groups across conditions were as follows: upper respiratory infection (URI): 626/3410 (18.4%), 413/2752 (15.0%), bronchitis: 689/1471 (46.8%), 742/1162 (64.0%), sinusitis: 5154/6131 (84.1%), 4250/4876 (87.2%), pharyngitis: 2308/2838 (81.3%), 1593/2126 (74.9%). Antibiotic prescriptions for all conditions decreased in the post-intervention period compared with those in the pre-intervention period, for both control and intervention groups. Reduction of antibiotic prescriptions for URI and bronchitis was greater for the group receiving education plus individualized feedback compared with that for the group receiving education alone (interaction term ratio 0.60, 95% CI 0.47 to 0.77 for URI; and interaction term ratio 0.42, 95% CI 0.32 to 0.55 for bronchitis), but not sinusitis and pharyngitis. CONCLUSION: Education plus individualized feedback in a telemedicine practice significantly decreased antibiotic prescription rates for upper respiratory tract infections and bronchitis, compared with education alone. Future studies should focus on tailoring antibiotic stewardship programs based on underlying conditions, and the maintenance of early reductions in antibiotic prescription.
Authors: Anthony W Chow; Michael S Benninger; Itzhak Brook; Jan L Brozek; Ellie J C Goldstein; Lauri A Hicks; George A Pankey; Mitchel Seleznick; Gregory Volturo; Ellen R Wald; Thomas M File Journal: Clin Infect Dis Date: 2012-03-20 Impact factor: 9.079
Authors: Adam A Powell; Hanna E Bloomfield; Diana J Burgess; Timothy J Wilt; Melissa R Partin Journal: Med Care Res Rev Date: 2013-08-05 Impact factor: 3.929
Authors: Katherine E Fleming-Dutra; Monina Bartoces; Rebecca M Roberts; Lauri A Hicks Journal: Open Forum Infect Dis Date: 2018-01-05 Impact factor: 3.835
Authors: Adam L Sharp; Yi R Hu; Ernest Shen; Richard Chen; Ryan P Radecki; Michael H Kanter; Michael K Gould Journal: Am J Manag Care Date: 2017-11-01 Impact factor: 2.229
Authors: Ateev Mehrotra; Suzanne Paone; G Daniel Martich; Steven M Albert; Grant J Shevchik Journal: JAMA Intern Med Date: 2013-01-14 Impact factor: 21.873
Authors: Charis Xuan Xie; Qiuzhe Chen; Cesar A Hincapié; Léonie Hofstetter; Chris G Maher; Gustavo C Machado Journal: J Am Med Inform Assoc Date: 2022-09-12 Impact factor: 7.942